CS logo
small CS logo
Centro Hospitalar Cova da Beira

Covilha, Portugal
Medical center in Covilhã
Centro Hospitalar Universitário Cova da Beira, EPE, Alameda Pêro da Covilhã, 6200-251 Covilhã

About Centro Hospitalar Cova da Beira


The Cova da Beira University Hospital Center is a Portuguese state-run hospital center in the Cova da Beira subregion.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Bayer
2
Galapagos NV
2
Octapharma
2
Biogen
1
Daiichi Sankyo, Inc.
1
Laval University
1
Takeda
1
Total Rows: 8

Clinical Trials at Centro Hospitalar Cova da Beira


During the past decade, Centro Hospitalar Cova da Beira conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44112200001100110000111122221100Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
2002-12-01
2004-04-01
Completed
311
The International Nocturnal Oxygen (INOX) Trial
2010-10-01
2019-01-01
Completed
243
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
2012-10-01
2018-04-01
Completed
120
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
2012-08-22
2019-12-13
Completed
10,471
Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
2014-05-06
2016-10-20
Completed
503
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
2015-12-22
2017-09-20
Completed
977

Rows per page:

1–15 of 15

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centro Hospitalar Cova da Beira" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Bayer" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored, "Octapharma" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar Cova da Beira" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 5Boehringer Ingelheim: 5Bayer: 2Bayer: 2Galapagos NV: 2Galapagos NV: 2Octapharma: 2Octapharma: 2Biogen: 1Biogen: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Laval University: 1Laval University: 1Takeda: 1Takeda: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Gilead Sciences: 2Gilead Sciences: 2Canadian Institutes ofHealth Research (CIHR):1Canadian Institutes ofHealth Research (CIHR):1

Clinical Trials Conditions at Centro Hospitalar Cova da Beira


According to Clinical.Site data, the most researched conditions in "Centro Hospitalar Cova da Beira" are "Atrial Fibrillation" (3 trials), "Crohn's Disease" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Colitis, Ulcerative" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Centro Hospitalar Cova da Beira" in a lesser frequency.

Clinical Trials Intervention Types at Centro Hospitalar Cova da Beira


Most popular intervention types in "Centro Hospitalar Cova da Beira" are "Drug" (11 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Filgotinib" (2 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centro Hospitalar Cova da Beira


The vast majority of trials in "Centro Hospitalar Cova da Beira" are 14 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Centro Hospitalar Cova da Beira


Currently, there are NaN active trials in "Centro Hospitalar Cova da Beira". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Centro Hospitalar Cova da Beira, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro Hospitalar Cova da Beira, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12Active, not recruiting: 1Active, not recruiting: 1Enrolling by invitation: 1Enrolling by invitation: 1Recruiting: 1Recruiting: 1